Alliance for Pharmacy Compounding (APC) Market Research Report
Background
Overview
The Alliance for Pharmacy Compounding (APC) is a non-profit trade association established in 1991, headquartered in Alexandria, Virginia. APC serves as the primary advocate for pharmacy compounding, representing over 600 small business compounding pharmacies, including pharmacists and technicians in both 503A and 503B settings, as well as prescribers, educators, researchers, and suppliers.
Mission and Vision
APC's mission is to protect patient access to compounded medications and advocate for fair regulation of compounding practices. The organization is committed to ensuring that millions of patients can continue to access essential compounded medications, thereby elevating pharmacy compounding as a key component of healthcare delivery across the United States.
Primary Area of Focus
APC focuses on advocating for compounding pharmacies and their patients on a range of state and federal issues affecting patient access to compounded medications. The organization also emphasizes education, providing resources to compounding professionals to ensure adherence to the highest ethical standards and regulatory compliance.
Industry Significance
As the voice for pharmacy compounding, APC plays a critical role in representing the interests of compounding professionals and their patients. The organization is instrumental in shaping policies and regulations that impact the compounding industry, ensuring that compounded medications remain a viable and accessible option within the healthcare system.
Key Strategic Focus
Core Objectives
- Advocacy: APC actively lobbies on Capitol Hill to assure that legislation elevates and preserves pure ingredient compounding, ensuring patient access to compounded medications.
- Education: The organization provides continuous education to compounding professionals, offering live and on-demand continuing education courses on scientific and regulatory compliance issues.
- Quality Assurance: APC collaborates with organizations like the Coalition for Compounding Excellence (CCE) to offer accreditation programs that help pharmacies demonstrate adherence to quality standards and support multi-state licensure efforts.
Specific Areas of Specialization
- Compounded Hormone Replacement Therapy (cBHT): APC is dedicated to protecting patient access to compounded hormone replacement therapies, advocating against legislative and regulatory challenges.
- Regulatory Compliance: The organization focuses on ensuring that compounding pharmacies adhere to the highest standards of quality and compliance, with all active ingredients sourced from FDA-registered facilities and manufacturers.
Key Technologies Utilized
APC employs various technologies to support its advocacy and educational initiatives, including:
- Webinars and Online Courses: Utilizing digital platforms to deliver live and on-demand continuing education programs to compounding professionals.
- Accreditation Programs: Collaborating with organizations like CCE to offer accreditation programs that help pharmacies demonstrate adherence to quality standards.
Primary Markets or Conditions Targeted
APC primarily targets the compounding pharmacy market, focusing on both 503A and 503B settings. The organization also addresses various health conditions that benefit from compounded medications, including autism, oncology, dermatology, ophthalmology, pediatrics, women's health, and animal health.
Financials and Funding
Funding History
As a non-profit organization, APC's funding primarily comes from membership dues, contributions, and program services. In the fiscal year ending December 2024, APC reported:
- Revenue: $3,140,200
- Expenses: $2,927,474
- Net Income: $212,726
- Total Assets: $1,595,327
- Total Liabilities: $313,909
- Net Assets: $1,281,418
Notable Investors
As a non-profit organization, APC does not have investors in the traditional sense. However, it receives support from various stakeholders, including compounding pharmacies, prescribers, educators, researchers, and suppliers. Notably, Letco Medical, LLC, a supplier of compounding products, has made multi-year contributions to APC to support its mission.
Intended Utilization of Capital
APC utilizes its funds to support its advocacy efforts, educational programs, quality assurance initiatives, and operational expenses. The organization is committed to ensuring that compounded medications remain accessible to patients and that compounding pharmacies adhere to the highest standards of quality and compliance.
Pipeline Development
As a trade association, APC does not have a product pipeline in the traditional sense. However, the organization is involved in various initiatives to support the compounding pharmacy industry, including:
- Accreditation Programs: APC has partnered with the Coalition for Compounding Excellence (CCE) to offer accreditation programs that help pharmacies demonstrate adherence to quality standards and support multi-state licensure efforts.
- Advocacy Efforts: The organization actively lobbies on Capitol Hill to ensure that legislation elevates and preserves pure ingredient compounding, ensuring patient access to compounded medications.
- Educational Initiatives: APC provides continuous education to compounding professionals, offering live and on-demand continuing education courses on scientific and regulatory compliance issues.
Technological Platform and Innovation
Proprietary Technologies
APC does not develop proprietary technologies but collaborates with organizations like CCE to offer accreditation programs that help pharmacies demonstrate adherence to quality standards.
Significant Scientific Methods
APC emphasizes the use of United States Pharmacopeia (USP) standards in compounding practices, focusing on adherence to USP <795>, <797>, and <800> guidelines. The organization collaborates with CCE to offer accreditation programs grounded in USP compliance.
AI-Driven Capabilities
APC does not currently utilize AI-driven capabilities in its operations.
Leadership Team
Key Executive Profiles
- Scott Brunner, CAE: Chief Executive Officer
Scott Brunner serves as the Chief Executive Officer of the Alliance for Pharmacy Compounding. Under his leadership, APC has expanded its advocacy efforts and educational programs to support the compounding pharmacy industry.
- Jennifer Burch: Board Chair
Jennifer Burch is the owner of Central Compounding in Durham, North Carolina. As Board Chair, she has been instrumental in guiding APC's strategic direction and advocating for the interests of compounding pharmacies.
- Philip Smyth: Board Chair
Philip Smyth is a pharmacy technician and serves as the Board Chair of APC. His leadership reflects the integral role of technicians in safe, high-quality compounding practices.
Leadership Changes
In 2025, Gina Besteman completed her term as APC Board Chair, and Philip Smyth succeeded her in this role.
Competitor Profile
Market Insights and Dynamics
The compounding pharmacy industry is characterized by a diverse range of small business pharmacies operating under 503A and 503B settings. The market is influenced by regulatory changes, technological advancements, and evolving patient needs. APC plays a pivotal role in advocating for policies that support the sustainability and growth of this industry.
Competitor Analysis
As a trade association, APC does not have direct competitors. However, it collaborates with various organizations to support the compounding pharmacy industry, including:
- Coalition for Compounding Excellence (CCE): Offers accreditation programs grounded in USP compliance, focusing on adherence to USP <795>, <797>, and <800> guidelines, which helps pharmacies maintain quality and regulatory standards.
